- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.9b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€214.60
7D
-5.5%
1Y
65.6%
UCB
Market Cap: €47.5b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€247.60
7D
-4.5%
1Y
50.6%
argenx
Market Cap: €48.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€796.00
7D
4.6%
1Y
70.8%